Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for cutaneous melanoma.

Julie R Lange1, Charles M Balch

  • 1Johns Hopkins Medicine, Department of Surgery, Johns Hopkins Hospital, Baltimore, MD 21287, USA. jlange@jhmi.edu

Surgical Oncology Clinics of North America
|October 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Quality in Surgery: Concepts, Measurement, Advances and Strategies for Improvement.

World journal of surgery·2026
Same author

Pathogenic germline variants associated with different HER2 expression among breast cancer patients.

Discover oncology·2026
Same author

The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection.

Ecancermedicalscience·2026
Same author

Ultrasound-guided, indocyanine green-directed robot-assisted surgery for breast cancer with negative margins: A single center study.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

Reply to: Critical Role of Model Selection in Evaluating AI Performance for Tumor Board Decision Making.

JCO clinical cancer informatics·2025
Same journal

Small Incisions, Big Impact-Robotic Surgery Is Revolutionizing Cancer Care.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive and Robotic Surgery for Cancer.

Surgical oncology clinics of North America·2026
Same journal

TeleSurgery: The Present and the Future for Minimally Invasive and Robotic Surgery.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive and Robotic Surgery for Rectal Cancer.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive/Robotic Surgery for Colon Cancer.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery in Liver Transplantation.

Surgical oncology clinics of North America·2026
See all related articles

Widespread population screening for melanoma is not supported by current data due to low mortality rates. Focus should be on high-risk individuals and groups with increased melanoma mortality risk.

Area of Science:

  • Dermatology
  • Oncology
  • Public Health

Background:

  • Melanoma incidence is high, but overall mortality is low, making population-wide screening benefits difficult to prove.
  • No randomized controlled trials have demonstrated mortality reduction through melanoma screening.
  • Early detection of melanoma is crucial as it is a treatable malignancy.

Purpose of the Study:

  • To evaluate the evidence for and against population-based screening for melanoma.
  • To identify specific high-risk groups that may benefit from targeted screening programs.

Main Methods:

  • Review of current data and evidence regarding melanoma screening efficacy.
  • Identification of specific populations with higher risk for melanoma development or mortality.

Related Experiment Videos

Main Results:

  • Current data do not support general population screening for melanoma.
  • High-risk groups, including those with familial melanoma, atypical mole syndrome, prior melanoma, or atypical nevi, are potential candidates for screening.
  • Certain demographics, such as low socioeconomic status individuals and white men over 50, face higher melanoma mortality risks.

Conclusions:

  • Targeted screening is more appropriate than widespread screening for melanoma.
  • Focusing screening efforts on individuals and groups at high risk for melanoma mortality is recommended.
  • Further research or evidence is needed to support mortality reduction claims for general melanoma screening.